Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1)

Eur J Med Chem. 2013 Apr:62:148-57. doi: 10.1016/j.ejmech.2012.09.047. Epub 2012 Oct 16.

Abstract

A series of MMP-1 inhibitors have been identified based upon a methyl rosmarinate scaffold using structure-based drug design methods. The best compound in the series showed an IC50 value of 0.4 μM. A docking study was conducted for compound (S)-10n in order to investigate its binding interactions with MMP-1. The structure-activity relationships (SAR) were also briefly discussed. Useful SAR was established which provides important guidelines for the design of future generations of potent inhibitors against MMP-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylates / chemical synthesis
  • Acrylates / chemistry
  • Acrylates / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Design
  • Humans
  • Matrix Metalloproteinase 1 / metabolism*
  • Matrix Metalloproteinase Inhibitors / chemical synthesis
  • Matrix Metalloproteinase Inhibitors / chemistry
  • Matrix Metalloproteinase Inhibitors / pharmacology*
  • Models, Molecular
  • Molecular Structure
  • Phenylpropionates / chemical synthesis
  • Phenylpropionates / chemistry
  • Phenylpropionates / pharmacology*
  • Structure-Activity Relationship

Substances

  • 2-(3-(3,4-bis(benzyloxy)phenyl)acryloyloxy)-3-(3,4-dimethoxyphenyl)propanoic acid
  • Acrylates
  • Matrix Metalloproteinase Inhibitors
  • Phenylpropionates
  • Matrix Metalloproteinase 1